Definium Therapeutics, Inc.

DFTXNASDAQHealthcareBiotechnology

$32.10- (-)1Y +150.99%

As of Oct 16, 2026 close

Market cap: $3.79B
P/E (TTM): -
Forward P/E: -
Dividend yield: -
52-week range: $10.47$49.70
Volume (live): -
Avg. volume (3M): 2.32M

Definium Therapeutics, Inc. (DFTX) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Definium Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 8 professional research analysts

Consensus Rating

Buy

Based on 8 unique analysts

Medium Confidence∞:1 Buy/Sell

Average Price Target

$76.63

+138.72% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest DFTX Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Sep 19, 2026	Francois Brisebois	LifeSci Capital	Maintains	Buy	$78.00
Sep 16, 2026	Paul Matteis	Stifel Nicolaus	Maintains	Buy	$60.00 → $67.00 +7.00 (+11.7%)
Sep 16, 2026	Michael Okunewitch	Maxim	Maintains	Buy	$55.00
Sep 15, 2026	Sumant Kulkarni	Canaccord Genuity	Reiterates	Buy	$64.00 → $78.00 +14.00 (+21.9%)
Sep 15, 2026	Justin Walsh	JonesTrading	Reiterates	Buy	$90.00
Sep 15, 2026	Christopher Chen	Baird	Maintains	Buy	$75.00 → $79.00 +4.00 (+5.3%)
Sep 14, 2026	Tazeen Ahmad	BofA Securities	Reiterates	Buy	$75.00 → $91.00 +16.00 (+21.3%)
Sep 14, 2026	Jay Olson	Oppenheimer	Maintains	Buy	$70.00 → $75.00 +5.00 (+7.1%)

Francois Brisebois

LifeSci Capital

BuyMaintains

$78.00

Sep 19

Paul Matteis

Stifel Nicolaus

BuyMaintains

$60.00 → $67.00

Sep 16

Michael Okunewitch

Maxim

BuyMaintains

$55.00

Sep 16

Sumant Kulkarni

Canaccord Genuity

BuyReiterates

$64.00 → $78.00

Sep 15

Justin Walsh

JonesTrading

BuyReiterates

$90.00

Sep 15

Christopher Chen

Baird

BuyMaintains

$75.00 → $79.00

Sep 15

Tazeen Ahmad

BofA Securities

BuyReiterates

$75.00 → $91.00

Sep 14

Jay Olson

Oppenheimer

BuyMaintains

$70.00 → $75.00

Sep 14

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Sep 19, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for DFTX?

The analyst consensus rating for DFTX is Buy, based on the latest ratings from 8 analysts over the last 90 days.

What is the average price target for DFTX?

The average 12-month price target for DFTX is $76.63, representing an upside of 138.7% from the Oct 16, 2026 close of $32.10.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.